Sign in
Results of phase III clinical trial subretinal gene therapy for RPE65-mediated Leber congenital amaurosis (LCA)
Abstract

Results of phase III clinical trial subretinal gene therapy for RPE65-mediated Leber congenital amaurosis (LCA)

Arlene V Drack, Daniel Chung, Stephen Russell, Jean Bennett, Jennifer Wellman, Zi Fan Yu, Albert Maguire, Edwin M Stone and Katherine High
Journal of AAPOS, Vol.20(4), pp.e4-e4
08/2016
DOI: 10.1016/j.jaapos.2016.07.015

View Online

Details

Metrics

19 Record Views